Safety and Efficacy Study of RT001 to Treat Moderate to Severe Lateral Canthal Lines
Clinical trial NCT00888914 · COMPLETED
Trial details
- NCT number
- NCT00888914
- Sponsor
- Revance Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-11-01
- Primary completion
- 2009-01-01
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.